Primary |
Obesity |
37.6% |
Drug Use For Unknown Indication |
15.3% |
Weight Control |
10.1% |
Hypertension |
9.8% |
Overweight |
5.2% |
Product Used For Unknown Indication |
5.1% |
Depression |
2.8% |
Asthma |
2.3% |
Hypothyroidism |
2.1% |
Epilepsy |
2.0% |
Pain |
1.2% |
Angina Pectoris |
1.0% |
Weight Decreased |
0.9% |
Blood Pressure |
0.9% |
Constipation |
0.7% |
Insomnia |
0.7% |
Back Pain |
0.6% |
Contraception |
0.6% |
Bipolar Disorder |
0.6% |
Diabetes Mellitus |
0.5% |
|
Epilepsy |
7.6% |
Death |
7.3% |
Cholelithiasis |
7.0% |
Myocardial Infarction |
7.0% |
Weight Increased |
7.0% |
Haematochezia |
6.7% |
Vomiting |
6.1% |
Pancreatitis |
5.4% |
Rectal Haemorrhage |
5.1% |
Palpitations |
4.5% |
Steatorrhoea |
4.5% |
Weight Decreased |
4.1% |
Chest Pain |
3.8% |
Thrombosis |
3.8% |
Cerebrovascular Accident |
3.5% |
Hypertension |
3.5% |
Vaginal Haemorrhage |
3.5% |
Cholecystectomy |
3.2% |
Diverticulitis |
3.2% |
Hypoglycaemia |
3.2% |
|
Secondary |
Obesity |
25.8% |
Drug Use For Unknown Indication |
15.3% |
Weight Control |
12.0% |
Hypertension |
9.9% |
Product Used For Unknown Indication |
5.1% |
Acne |
4.5% |
Asthma |
4.2% |
Overweight |
3.6% |
Constipation |
2.7% |
Contraception |
2.7% |
Epilepsy |
2.1% |
Angina Pectoris |
1.8% |
Ill-defined Disorder |
1.8% |
Hypothyroidism |
1.5% |
Atrial Fibrillation |
1.2% |
Depression |
1.2% |
Hepatitis C |
1.2% |
Hypertriglyceridaemia |
1.2% |
Weight Decreased |
1.2% |
Abdominal Pain |
0.9% |
|
Weight Increased |
12.3% |
Steatorrhoea |
9.6% |
International Normalised Ratio Increased |
6.8% |
Drug Ineffective |
5.5% |
Abdominal Pain |
4.1% |
Angina Pectoris |
4.1% |
Atrial Fibrillation |
4.1% |
Diarrhoea |
4.1% |
Drug Interaction |
4.1% |
Epilepsy |
4.1% |
Gallbladder Disorder |
4.1% |
Haematochezia |
4.1% |
Hyponatraemia |
4.1% |
Malabsorption |
4.1% |
Nausea |
4.1% |
Rectal Haemorrhage |
4.1% |
Sudden Death |
4.1% |
Varicose Ulceration |
4.1% |
Vision Blurred |
4.1% |
Weight Decreased |
4.1% |
|
Concomitant |
Drug Use For Unknown Indication |
17.1% |
Product Used For Unknown Indication |
12.0% |
Depression |
10.9% |
Hypertension |
8.0% |
Pain |
7.2% |
Diabetes Mellitus |
5.9% |
Anxiety |
4.5% |
Obesity |
3.7% |
Sleep Disorder |
3.6% |
Bipolar Disorder |
3.5% |
Schizophrenia |
3.2% |
Gastrooesophageal Reflux Disease |
2.9% |
Type 2 Diabetes Mellitus |
2.5% |
Asthma |
2.3% |
Contraception |
2.2% |
Arthritis |
2.1% |
Hypothyroidism |
2.1% |
Restless Legs Syndrome |
2.1% |
Hormone Replacement Therapy |
2.1% |
Rheumatoid Arthritis |
2.1% |
|
Weight Increased |
25.8% |
Type 2 Diabetes Mellitus |
11.8% |
Weight Decreased |
7.0% |
Nausea |
5.2% |
Spinal Disorder |
4.8% |
Pain |
4.4% |
Urinary Tract Infection |
4.4% |
Herpes Zoster |
3.9% |
Thyroid Disorder |
3.5% |
Vomiting |
3.5% |
Depression |
3.1% |
Sudden Death |
3.1% |
Death |
2.6% |
Dyspnoea |
2.6% |
Injury |
2.6% |
Skin Ulcer |
2.6% |
Uterine Leiomyoma |
2.6% |
Cholelithiasis |
2.2% |
Pruritus |
2.2% |
Suicide Attempt |
2.2% |
|
Interacting |
Hypertension |
21.4% |
Obesity |
21.4% |
Epilepsy |
14.3% |
Contraception |
7.1% |
Ill-defined Disorder |
7.1% |
Pain |
7.1% |
Pancreatitis Chronic |
7.1% |
Product Used For Unknown Indication |
7.1% |
Smoking Cessation Therapy |
7.1% |
|
Drug Interaction |
28.6% |
Blood Pressure Inadequately Controlled |
14.3% |
Epilepsy |
14.3% |
Maternal Exposure During Pregnancy |
14.3% |
Medication Residue |
14.3% |
Nausea |
14.3% |
|